October 08, 2021
COVID-19 Is Reshaping Global Pharmaceutical Competition – to Asia’s Benefit
By Hannah Elyse Sworn
The valuable experience gained by Asian companies during the pandemic could upset the West’s monopoly in high-value drugs more generally, with implications for global access to medicines.
April 01, 2020
How Wuhan Virologists Pegged Chloroquine as a Potential COVID-19 Cure
By Sribala Subramanian
In a paper published in February, before the disease even had a name, Chinese scientists noted an anti-malaria drug as a promising treatment.